抑制CAF-1组蛋白伴侣复合物触发胞质DNA与双链RNA感知通路并诱导肝细胞癌内在免疫
研究通过CRISPR/Cas9构建CAF-1复合物敲除的肝细胞癌(HCC)细胞系,在HCC细胞、裸鼠与免疫健全小鼠中观察其作用。CAF-1在人与小鼠HCC中显著上调并与患者预后不良相关。敲除CAF-1可抑制HCC生长,机制涉及复制应激、微核胞质DNA漏出、H3.3替换、内源性逆转录病毒元件表达及STING与双链RNA病毒感知通路激活,从而增强免疫检查点抑制剂疗效。
要点
- CAF-1复合物在人与小鼠HCC中显著上调,并与HCC患者预后不良相关。
- 敲除CAF-1在体外与体内模型中均显著抑制HCC生长。
- CAF-1缺失激活炎症反应与抗肿瘤免疫监视,显著增强免疫检查点抑制剂对HCC的抗癌效果。
核心结论
- CAF-1对HCC发生发展至关重要,靶向CAF-1可能唤醒抗肿瘤免疫反应,并可能与免疫检查点抑制剂治疗协同作用。
研究设计与样本
- 使用CRISPR/Cas9系统建立CAF-1复合物敲除细胞系,在HCC细胞系、裸鼠与免疫健全小鼠中研究CAF-1对HCC的作用。
- 采用RNA测序、染色质免疫沉淀测序(ChIP-Seq)与转座酶可及染色质高通量测序(ATAC-Seq)探索表观基因组与转录组变化。
主要发现
- CAF-1复合物在人与小鼠HCC中显著上调,并与HCC患者预后不良相关。
- 敲除CAF-1在体外与体内模型中均显著抑制HCC生长。
- CAF-1缺失诱导复制应激与染色质不稳定,最终导致胞质DNA以微核形式漏出。
- ChIP-Seq分析显示CAF-1敲除后发生大量H3.3组蛋白变体替换,常染色质H3.3富集增加染色质可及性并激活内源性逆转录病毒元件表达,即病毒模拟现象。
- 胞质微核与内源性逆转录病毒分别被干扰素基因刺激因子(STING)与双链RNA病毒感知通路识别,CAF-1敲除激活炎症反应与抗肿瘤免疫监视,显著增强免疫检查点抑制剂对HCC的抗癌效果。
临床怎么用
- 作者认为靶向CAF-1可能唤醒抗肿瘤免疫反应,并可能与免疫检查点抑制剂治疗在癌症治疗中协同作用。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Chromatin assembly factor 1 (CAF-1) is a replication-dependent epigenetic regulator that controls cell cycle progression and chromatin dynamics. In this study, we aim to investigate the immunomodulatory role and therapeutic potential of the CAF-1 complex in HCC. APPROACH AND RESULTS: CAF-1 complex knockout cell lines were established using the CRISPR/Cas9 system. The effects of CAF-1 in HCC were studied in HCC cell lines, nude mice, and immunocompetent mice. RNA-sequencing, ChIP-Seq, and assay for transposase accessible chromatin with high-throughput sequencing (ATAC-Seq) were used to explore the changes in the epigenome and transcriptome. CAF-1 complex was significantly upregulated in human and mouse HCCs and was associated with poor prognosis in patients with HCC. Knockout of CAF-1 remarkably suppressed HCC growth in both in vitro and in vivo models. Mechanistically, depletion of CAF-1 induced replicative stress and chromatin instability, which eventually led to cytoplasmic DNA leakage as micronuclei. Also, chromatin immunoprecipitation sequencing analyses revealed a massive H3.3 histone variant replacement upon CAF-1 knockout. Enrichment of euchromatic H3.3 increased chromatin accessibility and activated the expression of endogenous retrovirus elements, a phenomenon known as viral mimicry. However, cytosolic micronuclei and endogenous retroviruses are recognized as ectopic elements by the stimulator of interferon genes and dsRNA viral sensing pathways, respectively. As a result, the knockout of CAF-1 activated inflammatory response and antitumor immune surveillance and thereby significantly enhanced the anticancer effect of immune checkpoint inhibitors in HCC. CONCLUSIONS: Our findings suggest that CAF-1 is essential for HCC development; targeting CAF-1 may awaken the anticancer immune response and may work cooperatively with immune checkpoint inhibitor treatment in cancer therapy.
引用
- Chan FF, Yuen VW, Shen J, et al. Inhibition of CAF-1 histone chaperone complex triggers cytosolic DNA and dsRNA sensing pathways and induces intrinsic immunity of hepatocellular carcinoma. Hepatology. 2023. PMID: 38051950. doi:10.1097/HEP.0000000000000709
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。